Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: A novel EBV latency characterized by the absence of EBV-encoded small RNA expression

Virology

Volumn 256, Issue 2, 1999, Pages 196-202

  Sugawara, Yasuhiko ^a,b   Mizugaki, Yuzo ^a   Uchida, Toshikazu ^c   Torii, Tetsuo ^a   Imai, Shosuke ^a   Makuuchi, Masatoshi ^b   Takada, Kenzo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; VIRUS RNA;

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; HUMAN; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS GENOME; VIRUS LATENCY; VIRUS LOAD; VIRUS REPLICATION;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0033541373     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9619     Document Type: Article

References (19)

1. Allan G. J., Rowe D. T. Size and stability of the Epstein-Barr virus major internal repeat (IR-1) in Burkitt's lymphoma and lymphoblastoid cell lines. Virology. 197:1989;489-498.
2. Beasley R. P., Hwang L.-Y., Lin C.-C., Chien C.-S. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22707 men in Taiwan. Lancet. 8256:1981;1129-1133.
3. Chang K. L., Chen Y. Y., Shibata D., Weiss L. M. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn. Mol. Pathol. 1:1992;246-255.
4. Gilligan K., Rajadurai P., Resnick L., Raab-Traub N. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc. Natl. Acad. Sci. USA. 87:1990;8790-8794.
5. Howe J. G., Shu M. D. Epstein-Barr virus small RNA (EBER) genes: Unique transcription units that combine RNA polymerase II and III promoter elements. Cell. 57:1989;825-834.
6. Imai S., Koizumi S., Sugiura M., Tokunaga M., Uemura Y., Yamamoto N., Tanaka S., Sato E., Osato T. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc. Natl. Acad. Sci. USA. 91:1994;9131-9135.
7. Imai S., Nishikawa J., Takada K. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J. Virol. 72:1998;4371-4378.
8. Kerr B. M., Lear A. L., Rowe M., Croom-Carter D., Young L. S., Rookes S. M., Gallimore P. H., Rickinson A. B. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: Cell phenotype dependence of virus promoter usage. Virology. 187:1992;189-201.
9. Kiyosawa K., Sodeyama T., Tanaka E., Gibo Y., Yoshizawa K., Nakano Y., Furuta S., Akahane Y., Nishioka K., Purcell R. H., Alter H. J. Interrelationship of blood transfusion, non-A, non-B and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology. 12:1990;671-675.
10. Matsuo T., Heller M., Petti L., O'Shiro E., Kieff E. Persistence of the entire Epstein-Barr virus genome integrated into human lymphocyte DNA. Science. 226:1984;1322-1325.
11. Obayashi A., Okochi K., Mayumi M. Familial clustering of asymptomatic carriers of Australia antigen and patients with chronic liver disease or primary liver cancer. Gastroenterology. 62:1972;618-625.
12. Raab-Traub N., Flynn K. The structure of the termini of Epstein-Barr virus as a marker of clonal cellular proliferation. Cell. 47:1986;883-889.
13. Resnick R. H., Stone K., Antonioli D. Primary hepatocellular carcinoma following non-A, non-B posttransfusion hepatitis. Dig. Dis. Sci. 28:1983;908-911.
14. Rickinson A. B., Kieff E. Epstein-Barr virus. Fields B. N., Howley P. M. Fields Virology. 1996;2397-2446 Lippincott-Raven Publishers, Philadelphia.
15. Rowe M., Rowe D. T., Gregory C. D., Young L. S., Farrell P. J., Rupani H. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J. 6:1987;2743-2751.
16. Saito I., Servenius B., Comption T., Fox R. I. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren's syndrome. J. Exp. Med. 169:1989;2191-2198.
17. Sugiura M., Imai S., Tokunaga M., Koizumi S., Uchizawa M., Okamoto K., Osato T. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: Unique viral latency in the tumor cells. Br. J. Cancer. 74:1996;625-631.
18. Tierney R. J., Steven N., Young L. S., Rickinson A. B. Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68:1994;7374-7385.
19. Wagner H. J., Bein G., Bitsch A., Kirchner H. Detection and quantification of latently infected B lymphocytes in Epstein-Barr virus-seropositive, healthy individuals by polymerase chain reaction. J. Clin. Microbiol. 30:1992;2826-2829.